SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 273 filers reported holding SAGE THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.75 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $295,000 | -22.8% | 4,086 | +49.9% | 0.03% | -17.1% |
| Q3 2019 | $382,000 | -23.9% | 2,725 | -0.5% | 0.04% | -22.6% |
| Q2 2019 | $502,000 | +43.8% | 2,738 | +24.8% | 0.05% | -35.4% |
| Q1 2019 | $349,000 | +152.9% | 2,194 | +52.7% | 0.08% | +148.5% |
| Q4 2018 | $138,000 | -53.1% | 1,437 | -30.9% | 0.03% | -43.1% |
| Q3 2018 | $294,000 | +2.8% | 2,081 | +13.8% | 0.06% | +1.8% |
| Q2 2018 | $286,000 | +130.6% | 1,829 | +137.8% | 0.06% | +119.2% |
| Q1 2018 | $124,000 | -26.6% | 769 | -25.0% | 0.03% | -21.2% |
| Q4 2017 | $169,000 | – | 1,026 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,966,688 | $120,204,000 | 10.81% |
| Integral Health Asset Management, LLC | 230,000 | $14,058,000 | 4.30% |
| Asymmetry Capital Management, L.P. | 102,462 | $6,262,000 | 4.02% |
| ACUTA CAPITAL PARTNERS, LLC | 225,000 | $13,752,000 | 3.74% |
| DAFNA Capital Management LLC | 158,306 | $9,676,000 | 3.14% |
| Bain Capital Life Sciences Investors, LLC | 499,100 | $30,505,000 | 2.84% |
| Boxer Capital, LLC | 1,094,000 | $66,865,000 | 2.31% |
| Palo Alto Investors LP | 590,200 | $36,073,000 | 1.98% |
| Logos Global Management LP | 250,000 | $15,280,000 | 1.96% |
| Bellevue Group AG | 1,579,504 | $96,539,000 | 1.33% |